ZMYND8 and breast cancer: It has been shown that, however, upregulation of ZMYND8 by hypoxia-inducible factor (HIF) or ZMYND8 overexpression via positive feedback of the estrogen receptor (ER) pathway was correlated with poor prognosis in patients of breast cancer [127].